Company / Capital Expenditures
Pulmonx Corp Capital Expenditures History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$1.4M
FY2025
5-year range
$807.0K / $3.7M
FY2021-FY2025
Trend
+79.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Capital Expenditures returned to growth in FY2025 after 2 years of decline, reaching $1M.
Based on SEC 10-K filings.
$1M in FY2025 with a 5-year CAGR of +35.6%.
Improved from $1M to $1M over the past 2 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -26.7%
- 5-Year CAGR
- +35.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +35.6%, indicating consistent growth.
- In FY2025, capital expenditures increased 79.3% year-over-year.
- Peak capital expenditures was recorded in FY2022.
- Lowest capital expenditures in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.54 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.4M | +79.3% |
| FY2024 | $807.0K | -38.8% |
| FY2023 | $1.3M | -64.1% |
| FY2022 | $3.7M | +303.0% |
| FY2021 | $911.0K | +188.3% |
| FY2020 | $316.0K | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026